Oncogenic K-Ras suppresses global miRNA function

被引:4
|
作者
Shui, Bing [1 ,2 ,3 ]
Beyett, Tyler S. [1 ,4 ]
Chen, Zhengyi [6 ]
Li, Xiaoyi [9 ]
Rocca, Gaspare La [8 ]
Gazlay, William M. [1 ,4 ,5 ]
Eck, Michael J. [1 ,4 ]
Lau, Ken S. [6 ,7 ]
Ventura, Andrea [8 ]
Haigis, Kevin M. [1 ,2 ,10 ]
机构
[1] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA
[2] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Boston, MA 02215 USA
[3] Harvard Med Sch, Program Biol & Biomed Sci, Div Med, Boston, MA 02115 USA
[4] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA
[5] Univ Massachusetts, Dept Chem, Boston, MA 02125 USA
[6] Vanderbilt Univ, Epithelial Biol Ctr, Med Ctr, Nashville, TN 37232 USA
[7] Vanderbilt Univ, Dept Cell & Dev Biol, Chem & Phys Biol Program, Sch Med, Nashville, TN 37232 USA
[8] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA
[9] Mem Sloan Kettering Canc Ctr, Louis V Gerstner Jr Grad Sch Biomed Sci, New York, NY 10065 USA
[10] Harvard Med Sch, Harvard Digest Dis Ctr, Boston, MA 02215 USA
基金
美国国家卫生研究院;
关键词
SOMATIC ACTIVATION; RNA-BINDING; IN-VIVO; PHOSPHORYLATION; KRAS; EXPRESSION; PROTEINS; REVEALS; PROLIFERATION; CLASSIFICATION;
D O I
10.1016/j.molcel.2023.06.008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
K-Ras frequently acquires gain-of-function mutations (K-RasG12D being the most common) that trigger significant transcriptomic and proteomic changes to drive tumorigenesis. Nevertheless, oncogenic K-Ras induced dysregulation of post-transcriptional regulators such as microRNAs (miRNAs) during oncogenesis is poorly understood. Here, we report that K-RasG12D promotes global suppression of miRNA activity, resulting in the upregulation of hundreds of targets. We constructed a comprehensive profile of physiological miRNA targets in mouse colonic epithelium and tumors expressing K-RasG12D using Halo-enhanced Argonaute pull-down. Combining this with parallel datasets of chromatin accessibility, transcriptome, and proteome, we uncovered that K-RasG12D suppressed the expression of Csnk1a1 and Csnk2a1, subsequently decreasing Ago2 phosphorylation at Ser825/829/832/835. Hypo-phosphorylated Ago2 increased binding to mRNAs while reducing its activity to repress miRNA targets. Our findings connect a potent regulatory mechanism of global miRNA activity to K-Ras in a pathophysiological context and provide a mechanistic link between oncogenic K-Ras and the post-transcriptional upregulation of miRNA targets.
引用
收藏
页码:2509 / +
页数:29
相关论文
共 50 条
  • [1] Physiological analysis of oncogenic K-Ras
    Perez-Mancera, Pedro Antonio
    Tuveson, David A.
    REGULATORS AND EFFECTORS OF SMALL GTPASES: RAS FAMILY, 2006, 407 : 676 - +
  • [2] Abrogating Ras abnormal function by targeting Ras oligomers: Identification of dimer interface for oncogenic K-Ras
    Srivastava, Priyanka P.
    Dolino, Drew
    Gorfe, Alemayehu A.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
  • [3] Oncogenic K-ras "addiction" and synthetic lethality
    Singh, Anurag
    Settleman, Jeff
    CELL CYCLE, 2009, 8 (17) : 2676 - 2677
  • [4] Acute sensitivity of the oral mucosa to oncogenic K-ras
    van der Weyden, Louise
    Alcolea, Maria P.
    Jones, Philip H.
    Rust, Alistair G.
    Arends, Mark J.
    Adams, David J.
    JOURNAL OF PATHOLOGY, 2011, 224 (01): : 22 - 32
  • [5] Oncogenic K-Ras requires activation for enhanced activity
    Huang, H.
    Daniluk, J.
    Liu, Y.
    Chu, J.
    Li, Z.
    Ji, B.
    Logsdon, C. D.
    ONCOGENE, 2014, 33 (04) : 532 - 535
  • [6] Oncogenic K-Ras requires activation for enhanced activity
    H Huang
    J Daniluk
    Y Liu
    J Chu
    Z Li
    B Ji
    C D Logsdon
    Oncogene, 2014, 33 : 532 - 535
  • [7] Blocking K-Ras Interaction With the Plasma Membrane Is a Tractable Therapeutic Approach to Inhibit Oncogenic K-Ras Activity
    Henkels, Karen M.
    Rehl, Kristen M.
    Cho, Kwang-jin
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 8
  • [8] Chemical acylation of an acquired serine suppresses oncogenic signaling of K-Ras(G12S)
    Zhang, Ziyang
    Guiley, Keelan Z.
    Shokat, Kevan M.
    NATURE CHEMICAL BIOLOGY, 2022, 18 (11) : 1177 - +
  • [9] Chemical acylation of an acquired serine suppresses oncogenic signaling of K-Ras(G12S)
    Ziyang Zhang
    Keelan Z. Guiley
    Kevan M. Shokat
    Nature Chemical Biology, 2022, 18 : 1177 - 1183
  • [10] The K-ras let-7 miRNA binding site variant and K-ras mutations in colon cancer
    Dalay, Nejat
    Yalniz, Zubeyde
    Gurbuz, Orkun
    MOLECULAR CANCER RESEARCH, 2014, 12